The AMP studies are the first ones designed to find out if the VRC01 antibody prevents HIV infection.
Dithutopatlisiso tsa AMP ke tsa ntlha tse di diretsweng go batlisisa gore a selwantsha-mogare sa VRC01 se thibela tshwatso ya HIV.